Close

Eiger BioPharmaceuticals (EIGR) Doses First Patient in Phase 2 LIMT HDV Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to Eiger BioPharmaceuticals (EIGR) Doses First Patient in Phase 2 LIMT HDV Study